sCLU is highly overexpressed in hepatocellular carcinoma (HCC) and contributes to oxaliplatin resistance by downregulating the expression of Gadd45a and activating the PI3K/Akt pathway [198]. This evidence concerns the gene GADD45A and hepatocellular carcinoma.